Schulam to Serve as Interim Director of Yale Cancer Center as Lynch Plans to Step Down

Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”

Five years ago, Tyler Jacks took on a new challenge, becoming president of Break Through Cancer, a foundation that has pledged to spend at least $500 million to support research projects across top tier cancer centers.

March 13, 2026

Vol.52 No.10

By Paul Goldberg

Regulatory News

Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)

Amid deepening controversy, Vinay Prasad, FDA’s top clinician and scientist, and director of its Center for Biologics Evaluation and Research, will be leaving the agency.

March 13, 2026

Vol.52 No.10

By Claire Marie Porter

Regulatory News

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncology
Atara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

On Jan. 9, Pierre Fabre Pharmaceuticals received a “complete response letter” from FDA: its application for the T-cell therapy tabelecleucel (Ebvallo) was getting a hard No.

As more people are surviving cancer, we must continue funding bold science

The cancer research community has a reason to celebrate. For the first time, 70% of people are living at least five years beyond their cancer diagnosis. And, as importantly, cancer death rates have been dropping relentlessly—by more than a third since 1991.

March 13, 2026

Vol.52 No.10

By Karen E. Knudsen

Cancer History Project

The murder of Alexei Navalny is part of Russia’s macabre fascination with poisons
A gallop through history of poisonings—from hemlock, to mustard gas, to Polonium-210, to dart frog poison

Poisoning one’s political rivals has a long history. In 399 B.C., an Athenian court found Socrates guilty of “impiety and the corruption of youth” and ordered him to drink a fatal dose of hemlock.

HHS postpones third USPSTF meeting in a row

Yet another U.S. Preventative Services Task Force meeting is postponed—the third missed meeting since the start of the second Trump administration.

March 13, 2026

Vol.52 No.10

By Sara Willa Ernst

Schulam to Serve as Interim Director of Yale Cancer Center as Lynch Plans to Step Down

YOU MAY BE INTERESTED IN

Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”

Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncology
Atara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

As more people are surviving cancer, we must continue funding bold science

The murder of Alexei Navalny is part of Russia’s macabre fascination with poisons
A gallop through history of poisonings—from hemlock, to mustard gas, to Polonium-210, to dart frog poison

HHS postpones third USPSTF meeting in a row

Renew today!

Subscriber content

Never miss an issue!

Login

Schulam to Serve as Interim Director of Yale Cancer Center as Lynch Plans to Step Down

YOU MAY BE INTERESTED IN

Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”

Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncologyAtara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

As more people are surviving cancer, we must continue funding bold science

The murder of Alexei Navalny is part of Russia’s macabre fascination with poisonsA gallop through history of poisonings—from hemlock, to mustard gas, to Polonium-210, to dart frog poison

HHS postpones third USPSTF meeting in a row

Never miss an issue!

Login

Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncology
Atara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.”

The murder of Alexei Navalny is part of Russia’s macabre fascination with poisons
A gallop through history of poisonings—from hemlock, to mustard gas, to Polonium-210, to dart frog poison